Recent Advances on the Development of Pharmacotherapeutic Agents on the Basis of Human Serum Albumin

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|21|14|1866-1888

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.21, Iss.14, 2015-04, pp. : 1866-1888

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibition of drug binding to human serum albumin by cholecystographic agents

By Bertucci C.   Cimitan S.  

Il Farmaco, Vol. 58, Iss. 9, 2003-09 ,pp. : 901-908

Elsevier

Access to resources Recommend Favorite

Evaluation of Interactions Between Platinum-/Ruthenium-Based Anticancer Agents and Human Serum Albumin: Development of HSA Carrier for Metal-Based Drugs

By  

Current Pharmaceutical Design, Vol. 21, Iss. 14, 2015-04 ,pp. : 1848-1861

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in the Development of Amyloid Imaging Agents

By  

Current Topics in Medicinal Chemistry, Vol. 7, Iss. 18, 2007-09 ,pp. : 1773-1789

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in the Development of Catalytic Inhibitors of Human DNA Topoisomerase II As Novel Anticancer Agents

By  

Current Medicinal Chemistry, Vol. 20, Iss. 5, 2013-02 ,pp. : 694-709

Bentham Science Publishers

Access to resources Recommend Favorite

A Comprehensive Review on Recent advances in Synthesis

By  

Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Inflammatory and Anti-Allergy Agents), Vol. 14, Iss. 2, 2015-08 ,pp. : 98-112

Bentham Science Publishers

Access to resources Recommend Favorite